Coca-Cola has struggled to integrate its $5.6 billion purchase of BodyArmor with Powerade, which led to more “disruption in the short-term” than expected, according to CEO James Quincey.
Body Armor’s sales declined in the latest quarter.
The Atlanta-based Coca-Cola is optimistic that BodyArmor will eventually complement Powerade, its other big offering in the sports-drink category, as it aims to better compete against industry heavyweight, Pepsi-owned Gatorade.
BodyArmor’s purchase is the largest acquisition in Coca-Cola’s history.
In 2018, Coca-Cola first paid an undisclosed sum for a 15% share in BodyArmor, which had revenues of around $250 million.
That amount increased to more than $1 billion in 2021 when it acquired the remaining shares of brand to increase the variety of beverages it offers.
Through the use of coconut water, low sodium and high potassium levels, the lack of artificial colors, and the addition of sugar in place of high fructose corn syrup, the fast-growing, healthier sports drink gained popularity among consumers.
The purchase of BodyArmor by Coca-Cola led to a big bet that the beverage would play a key role in building out its liquid offerings and repositioning the business into a “total beverage company.”
Coca-Cola’s U.S. sports-drink market share had slipped in recent months. Still, the Coke chief remains optimistic this year will be a turning point for BodyArmor.


Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift
Gold Prices Steady as Markets Await Key U.S. Data and Expected Fed Rate Cut
China Urged to Prioritize Economy Over Territorial Ambitions, Says Taiwan’s President Lai
How did sport become so popular? The ancient history of a modern obsession
Asian Currencies Edge Higher as Markets Look to Fed Rate Cut; Rupee Steadies Near Record Lows
From Messi to Mika Häkkinen: how top athletes can slow down time
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Asian Markets Stabilize as Wall Street Rebounds and Rate Concerns Ease
Pepe Marti’s Epic F2 Win: ‘Game-Changer’ in Championship Battle as Abbi Pulling Steals F1 Academy Spotlight
UPS MD-11 Crash Prompts Families to Prepare Wrongful Death Lawsuit
Europe Confronts Rising Competitive Pressure as China Accelerates Export-Led Growth
Trump Attends Super Bowl Amid Cheers, Boos, and Political Divide
Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations
Gold Prices Edge Higher as Markets Await Key U.S. PCE Inflation Data 



